Jean-Pierre Pignon

Surgery · 2001–2021

A researcher in the Science corpus: 17 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Jean-Pierre Pignon trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Julian P. T. Higgins
  2. S. Thompson
  3. J. Bourhis

Who trusts Jean-Pierre Pignon overall

  1. Balázs Győrffy

Papers from Jean-Pierre Pignon's perspective

Ordered by how strongly the researchers Jean-Pierre Pignon trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
  2. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. (New England Journal of Medicine)
  3. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. (New England Journal of Medicine)
  4. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. (Journal of Clinical Oncology)
  5. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death (Journal of Experimental Medicine)
  6. Calreticulin exposure dictates the immunogenicity of cancer cell death (Nature Medicine)
  7. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans (Nature Genetics)
  8. High mobility group box 1 protein interacts with multiple Toll-like receptors. (American Journal of Physiology - Cell Physiology)
  9. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. (The Lancet Oncology)
  10. The Consensus Molecular Subtypes of Colorectal Cancer (Nature Medicine)

Their papers